Overview

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction

Status:
Terminated

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to assess whether single oral doses of Riociguat safely improve the cardiovascular function in patients with pulmonary hypertension associated with left ventricular diastolic dysfunction

Phase:

Phase 2

Details

Lead Sponsor:

Bayer

Treatments:

Riociguat